Pura Vida
Well-Known Member
A single outpatient procedure may soon make it possible for people with type 2 diabetes to maintain glycemic control without the use of expensive medication.
The preliminary study, which was fully funded by Endogenex — the company behind the technology — will be presented at this year’s Digestive Disease Week. The procedure works by using electrical pulses to induce changes to the lining of the duodenum, the first part of the small intestine.
“The potential for controlling diabetes with a single endoscopic treatment is spectacular,” said Celine Busch, the study’s lead researcher and a PhD candidate in gastroenterology at Amsterdam University Medical Center. “One of the biggest advantages of this treatment is that a single outpatient endoscopic procedure provides glycemic control, a potential improvement over drug treatment, which depends on patients taking their medication day in, day out.”
The preliminary study, which was fully funded by Endogenex — the company behind the technology — will be presented at this year’s Digestive Disease Week. The procedure works by using electrical pulses to induce changes to the lining of the duodenum, the first part of the small intestine.
“The potential for controlling diabetes with a single endoscopic treatment is spectacular,” said Celine Busch, the study’s lead researcher and a PhD candidate in gastroenterology at Amsterdam University Medical Center. “One of the biggest advantages of this treatment is that a single outpatient endoscopic procedure provides glycemic control, a potential improvement over drug treatment, which depends on patients taking their medication day in, day out.”